Skip to content

13F-HR filed by DCVC Opportunity Fund II GP, LLC

DCVC Opportunity Fund II GP, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 4 holding rows worth $120,850,000.

Accession
0001104659-22-022519
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 4 entries on the cover page, a total value of $120,850,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,850,000 with VALUE read as thousands by filing date, 13F file number 028-22056. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
RECURSION PHARMACEUTICALS IN75629V104CL A3,951,141$67,683,000thousands by filing date
SENTINELONE INC81730H109CL A783,462$39,557,000thousands by filing date
ROCKET LAB USA INC773122956PUT795,067$9,763,000thousands by filing date
DESKTOP METAL INC25058X105COM CL A777,166$3,847,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-022519this filing2022-02-14acceptance time not in the bulk data set
13F-HR/A 0001104659-22-118014 base2022-11-14acceptance time not in the bulk data set